carbamazepine
Generic: carbamazepine
Labeler: coupler llcDrug Facts
Product Profile
Brand Name
carbamazepine
Generic Name
carbamazepine
Labeler
coupler llc
Dosage Form
CAPSULE, EXTENDED RELEASE
Routes
Active Ingredients
carbamazepine 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
67046-1455
Product ID
67046-1455_2d936849-9c55-5b7f-e063-6294a90aaa6c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA076697
Listing Expiration
2026-12-31
Marketing Start
2025-02-07
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
670461455
Hyphenated Format
67046-1455
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
carbamazepine (source: ndc)
Generic Name
carbamazepine (source: ndc)
Application Number
ANDA076697 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (67046-1455-3)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2d936849-9c55-5b7f-e063-6294a90aaa6c", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["200131"], "spl_set_id": ["2d936849-9c80-5b7f-e063-6294a90aaa6c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Coupler LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (67046-1455-3)", "package_ndc": "67046-1455-3", "marketing_start_date": "20250207"}], "brand_name": "Carbamazepine", "product_id": "67046-1455_2d936849-9c55-5b7f-e063-6294a90aaa6c", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "67046-1455", "generic_name": "carbamazepine", "labeler_name": "Coupler LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "300 mg/1"}], "application_number": "ANDA076697", "marketing_category": "ANDA", "marketing_start_date": "20250207", "listing_expiration_date": "20261231"}